With the development of the epidemic in COVID-19, many materials have been allowed to be purchased and used by people themselves. For example, the most popular COVID-19 test reagent was recently allowed to be purchased by individuals, which is a good example. Regarding the production of antibacterial and antiviral masks, the State Administration of Medical Supplies said that relevant experts will be organized to demonstrate many aspects of masks, and specific manufacturers will be allowed to produce them after the demonstration is passed. It is normal to demonstrate antibacterial and antiviral mask products, because antibacterial and antiviral masks use antibacterial agents after all. How much dosage of antibacterial agent is used and how to ensure that antibacterial agent will not cause safety problems in production become the key.
Status 1: At present, the product is still in the demonstration stage.
At present, the product is still in the demonstration stage, and many manufacturers have not yet started to produce this mask. After all, the State Administration of Medical Supplies has not formulated corresponding standards for the production and sale of such masks. As far as the effectiveness of the product is concerned, it is difficult to say whether the product has a more effective protective effect and whether it can effectively filter out external bacteria and readable substances. As far as product safety is concerned, due to the use of antibacterial agents, the dosage of antibacterial agents is harmless to human body, and how to combine the production of antibacterial agents with the production of woven fabrics in the production process to ensure safe production has become a key issue. Only when the effectiveness and safety of antibacterial and antiviral masks are demonstrated and standards are formulated can pharmaceutical companies put their products on the market.
State 2: This product has a great market prospect.
If the antibacterial and antiviral mask works well, it still has great development prospects. With the further development of the epidemic in COVID-19, if the protective effect of this mask is better than any previous medical mask, and there are no major safety problems in the production process, it will not only stimulate consumers to be more willing to buy this mask, but also stimulate pharmaceutical companies to produce this mask to earn more money. From these two aspects, the development of antibacterial and antiviral mask products has a broad market.